Skip to content

Comparison of Two Hydroxy-apatite Coated Hip Stems

Randomized Controlled Trial Comparison of Two Hydroxy-apatite Coated Hip Stems Utilizing Radiostereometric Analysis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03577522
Enrollment
56
Registered
2018-07-05
Start date
2018-07-19
Completion date
2024-01-30
Last updated
2025-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Osteoarthritis

Brief summary

In this study, the investigators propose to randomize 80 subjects to receive either the Avenir cementless hip stem or a competing, HA-coated hip stem (Corail, DePuy-Synthes) and follow these patients for a period of 2 years post-surgery. The investigators aim to determine if the Avenir cementless hip stem has equivalent or better fixation and clinical outcomes compared to a predicate hip stem with longer clinical history.

Detailed description

This is a multi-center, randomized controlled trial of patients undergoing primary total hip arthroplasty. This study will be focused on enrollment at a single site with possible expansion to additional centers should patient enrollment occur at a slower than expected rate. Decision to expand the study to additional centers will be mutually agreed upon by both the clinical site and the study sponsor. Patients will be randomized to two study groups: 1. Zimmer Avenir cementless, HA-coated femoral hip stem with matching Trilogy IT cup; 2. DePuy-Synthes Corail cementless, HA-coated, non-collared femoral hip stem with matching Pinnacle cup Patient allocation to the study groups will occur following a randomized 4-block design.

Interventions

DEVICEAvenir cementless hip stem

Avenir cementless hip stem vs Corail HA-coated hip stem

DEVICECorail HA-coated hip stem

Avenir cementless hip stem vs Corail HA-coated hip stem

Sponsors

Canadian Radiostereometric Analysis Network
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 79 Years
Healthy volunteers
Yes

Inclusion criteria

* Symptomatic osteoarthritis of the hip undergoing primary total hip arthroplasty * Between the ages of 18 and 79 inclusive * Patients willing and able to comply with follow-up requirements and self-evaluations * Ability to give informed consent

Exclusion criteria

* Requires specialty implant (e.g., suspected metal allergy, coxa vera implant) * Avascular necrosis * Unresolved infection of the hip * Hip fracture * Hip dysplasia * At risk for loss to follow-up * Prior surgery to the ipsilateral hip * Severe proximal femoral deformity preventing the use of standard proximal press-fit femoral components * Medical condition precluding major surgery * Current or pending patient incarceration

Design outcomes

Primary

MeasureTime frameDescription
Migration2 yearsMeasured via radiosteriometric analysis

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026